pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
tulisokibart
Systemic Sclerosis (Scleroderma)
$MRKMerck & Co., Inc.
1 catalysts
Phase 3
(atisnolerbart + bremzalerbart + umesolerbart)
Birch Pollen Allergy
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
(betamethasone acetate + betamethasone sodium phosphate)
Celestone Soluspan ((betamethasone acetate + betamethasone sodium phosphate))
Cerebral Edema
$OGNOrganon & Co.
0 catalysts
← prev
page 3 of 13
next →
131
Pain89
Neurology1
Phase 2
(cilnidipine + tadalafil)
(cilnidipine [INN] + tadalafil)
Systemic Sclerosis (Scleroderma)
AISA Pharma Inc
0 catalysts
Marketed
(dextromethorphan + promethazine)
Promethazine DM ((dextromethorphan [INN] + promethazine [INN]))
Nasopharyngitis (Common Cold)
PAI Holding Co LLC
0 catalysts
Phase 3
(efgartigimod alfa + hyaluronidase (human recombinant))
Vyvgart Hytrulo ((efgartigimod alfa + hyaluronidase (human recombinant)-qvfc))
Idiopathic Inflammatory Myopathy (IIM)
$ARGXARGENX SE
0 catalysts
Marketed
(fluocinolone acetonide + neomycin)
Neo-Synalar ((fluocinolone acetonide + neomycin [INN]))
Psoriasis
Medicis Pharmaceutical Corp
0 catalysts
Marketed
(halobetasol propionate + tazarotene)
Duobrii ((halobetasol propionate + tazarotene))
Plaque Psoriasis (Psoriasis Vulgaris)
Ortho Dermatologics Inc
0 catalysts
Marketed
(hyaluronidase (recombinant, human) + immune globulin (human))
HyQvia (hyaluronidase (recombinant, human) + immune globulin (human))
Primary Immune Deficiency (PID)
Baxalta Inc
0 catalysts
Marketed
(hydrocortisone acetate + pramocaine)
Proctofoam HC ((hydrocortisone acetate + pramocaine [INN]))
Anorectal Inflammation
Mylan Specialty LP
0 catalysts
Preclinical
6SP-2406 ER
Sicca Syndrome (Sjogren)
6S Pharma LLC
0 catalysts
Phase 1
ABBV-547
Psoriasis
$ABBVAbbVie Inc.
0 catalysts
Preclinical
ACAR-198
Autoimmune Disorders
AbelZeta Inc
0 catalysts
Phase 1
ACE-1334
Systemic Sclerosis (Scleroderma)
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
ACE-1831
Immunoglobulin G4-Related Disease (IgG4-RD)
Acepodia Inc
0 catalysts
Phase 1
ACT-101
Myasthenia Gravis
Alpha Cancer Technologies Inc
0 catalysts
Preclinical
AChE Inhibitors
Acne Vulgaris
Attillaps Holdings Inc
0 catalysts
Phase 1
ALLO-329
Lupus Nephritis
$ALLOAllogene Therapeutics, Inc.
0 catalysts
Preclinical
APT-101
Idiopathic Pulmonary Fibrosis
APIE Therapeutics Inc
0 catalysts
Phase 1
ART-26.12
Chemotherapy Induced Peripheral Neuropathy
$ARTLARTELO BIOSCIENCES, INC.
0 catalysts
Phase 1
ASC-50
Plaque Psoriasis (Psoriasis Vulgaris)
Ascletis Pharma Inc
0 catalysts
Phase 1
ASC-930
Graft Versus Host Disease (GVHD)
ASC Therapeutics Inc
0 catalysts
Phase 1
AUR-200
Systemic Lupus Erythematosus
$AUPHAurinia Pharmaceuticals Inc.
0 catalysts
Phase 2
AZD-0120
Refractory Multiple Myeloma
Gracell Biotechnologies Inc
0 catalysts
pre_registration
Anti-inflammatory
Post-Operative Pain
Mitogen-activated protein kinase 11Mitogen-activated protein kinase 14
AimMax Therapeutics Inc
0 catalysts
Phase 2
Autologous Adipose-derived Stem Cells
Osteoarthritis
CellTex Therapeutics Corp
0 catalysts
Phase 1
BIIB-142
Lupus Nephritis
$BIIBBIOGEN INC.
0 catalysts
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
0 catalysts
Preclinical
BPC-157
Inflammation
PharmaTher Holdings Ltd
0 catalysts
Preclinical
Brecept
Systemic Sclerosis (Scleroderma)
RadBio
0 catalysts